Wide Scale Testing Beginning for COVID-19 Vaccines

Researchers are making so much progress in developing a vaccine against COVID-19 that the first wide-scale testing could begin in a matter of weeks.

The New York Times Coronavirus Vaccine Tracker says a vaccine developed by the 10-year-old biotech company Moderna expects to start wide-scale testing this month. If it does, it would mark an almost unprecedented acceleration of the clinical testing process.

Typically, testing and approving a new vaccine takes two or three years. Sometimes more. But under the federal government’s Operation Warp Speed, Modena received a fast-track designation from the Food and Drug Administration. It also got a $483 million award to further its Covid-19 vaccine.

Through its Coronavirus Vaccine Tracker The Times is updating the status of all the vaccines that have reached human testing, along with a selection of promising vaccines still being tested in cells or animals. Because of the number and especially speed at which bioscience and pharmaceutical firms are moving to develop a successful vaccine, the Tracker is being updated almost every day.

The World Health Organization lists 149 different vaccine projects underway worldwide. 17 are in clinical evaluation, meaning they are being tested in humans, either in small groups to ensure their safety and basic efficacy, or in hundreds to see the effect among different age groups.

The Vaccine Tracker lists five vaccine candidates that are in or about to launch Phase III testing, the broadest testing category where thousands of volunteers are enlisted to determine if the vaccine is widely effective and how well it protects people from becoming infected. That’s the test Moderna expects to begin soon.

A vaccine developed by AstraZeneca and the University of Oxford is already in Phase III testing in Brazil and South Africa and is in a simultaneous Phase II and III study in Europe. This program, like Moderna’s, is part of Operation Warp Speed.

The Vaccine Tracker lists two Chinese firms – Sinovac Biotech and Sinopharm – as ready to soon start broad testing of their respective vaccines. Sinopharm’s testing will be conducted in the United Arab Emirates. Sinovac plans to conduct its Phase III study in China and Brazil.

A fifth vaccine, which is not a vaccine specifically for COVID-19, but a sort of immune system booster, is being tested in Australia. Bacillus Calmette-Guerin, a vaccine originally developed for tuberculosis, has been found over its 100 year history to help fight off other types of infections and parasites. The Phase III testing will determine if it also helps protect against COVID-19.

Image by Angelo Esslinger

How to Answer Salary Expectations
General Interest Green Key News Worklife

How to Answer Salary Expectations

#WeAreGreenKey: Spotlight on Sean Coyne
Architecture + Engineering General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Sean Coyne

Questions to Ask During a Job Interview
General Interest Green Key News Human Resources Worklife

Questions to Ask During a Job Interview

#WeAreGreenKey: Spotlight on Angela Singh
General Interest Green Key News Human Resources Worklife

#WeAreGreenKey: Spotlight on Angela Singh

The Power of Work Friends
General Interest Green Key News Worklife

The Power of Work Friends

#WeAreGreenKey: Spotlight on Rachel Azzolini
Accounting + Finance General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Rachel Azzolini

The Effects of Quiet Quitting
General Interest Green Key News Worklife

The Effects of Quiet Quitting

#WeAreGreenKey: Spotlight on Karen Martinez
General Interest Green Key News Healthcare Worklife

#WeAreGreenKey: Spotlight on Karen Martinez

How to Address Strengths and Weaknesses in an Interview
General Interest Green Key News Human Resources Worklife

How to Address Strengths and Weaknesses in an Interview

Green Key Unlocked: Success as a Biometric Professional
General Interest Green Key News Pharma Worklife

Green Key Unlocked: Success as a Biometric Professional

Perks of Working Temp & Contract Roles
General Interest Green Key News Human Resources Worklife

Perks of Working Temp & Contract Roles

#WeAreGreenKey: Spotlight on Lindsay Smith
Accounting + Finance General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Lindsay Smith

Tips for Starting a New Job as a Remote Employee
General Interest Green Key News Worklife

Tips for Starting a New Job as a Remote Employee

#WeAreGreenKey: Spotlight on Kayla Jones
General Interest Green Key News Pharma Worklife

#WeAreGreenKey: Spotlight on Kayla Jones

Green Key Unlocked: Marketing Technology Consultants
General Interest

Green Key Unlocked: Marketing Technology Consultants

How to Write a Thank You Email
General Interest Green Key News Worklife

How to Write a Thank You Email

#WeAreGreenKey: Spotlight on Ben Johnson
General Interest Green Key News Professional Support Worklife

#WeAreGreenKey: Spotlight on Ben Johnson

How Social Media Can Grow Your Business
Creative General Interest Green Key News Worklife

How Social Media Can Grow Your Business

How to Take Pride Beyond June
General Interest Green Key News Human Resources Worklife

How to Take Pride Beyond June

#WeAreGreenKey: Spotlight on Mary Baynard
General Interest Green Key News Professional Support Worklife

#WeAreGreenKey: Spotlight on Mary Baynard

Latest Blog Posts
View All Posts
How to Answer Salary Expectations

How to Answer Salary Expectations

Whether when filling out the application, or during the offer process, you will likely be asked about your salary expectations...
Read More
#WeAreGreenKey: Spotlight on Sean Coyne

#WeAreGreenKey: Spotlight on Sean Coyne

Sean specializes in construction recruitment and has several years of experience within the industry.
Read More
Questions to Ask During a Job Interview

Questions to Ask During a Job Interview

If you’re a working professional, you’ve likely experienced the end of interview session, when the interviewer asks if you have...
Read More